You are here

Company Monitoring Page for JNJ

latest headlines for company on cafepharma

J&J's Darzalex makes FDA history with another myeloma nod in new patients

Fierce Pharma

Fri, 09/27/19 - 09:56 am

Tags:

JNJ, Darzalex, FDA, Multiple Myeloma

The Week Ahead In Biotech: Spotlight On ESMO Conference

Yahoo/Benzinga

Sun, 09/22/19 - 11:10 pm

HIV vaccine shows signs of cross-subtype protection

Fierce Biotech

Fri, 09/20/19 - 09:44 am

Tags:

vaccines, HIV, ALVAC‐HIV, Sanofi Pasteur, GSK, JNJ, South Africa, clinical trials

EASD: Novo's Ozempic tops Victoza, J&J's Invokana in double head-to-head win

Fierce Pharma

Tue, 09/17/19 - 03:41 pm

Tags:

Novo Nordisk, Ozempic, JNJ, Invokana, Victoza, diabetes, EASD

EASD: Lilly, BI tout new Jardiance kidney analysis as rival J&J nears FDA nod

Fierce Pharma

Tue, 09/17/19 - 11:00 am

Tags:

Eli Lilly, Boehringer Ingelheim, Jardiance, kidney disease, JNJ, EASD

J&J filing aims Tremfya at crowded psoriatic arthritis market

Pharmaforum

Tue, 09/17/19 - 10:06 am

Tags:

JNJ, psoriatic arthritis, Tremfya

Amgen's Kyprolis, J&J's Darzalex team up on myeloma survival win

Fierce Pharma

Mon, 09/16/19 - 09:25 am

Tags:

Amgen, Kyprolis, JNJ, Darzalex, Multiple Myeloma

J&J taps AlivaMab for multi-target antibody discovery effort

Fierce Biotech

Mon, 09/16/19 - 09:22 am

Tags:

JNJ, AlivaMab, antibody-drug conjugate, R&D

Drug companies pay for exclusive access to UK genetic data

Biopharma Dive

Thu, 09/12/19 - 11:35 am

Tags:

UK, genetic database, Amgen, AstraZeneca, JNJ, GSK

Janssen’s MS pill outshines Sanofi’s Aubagio in phase 3 trial

Pharmaforum

Thu, 09/12/19 - 10:28 am

Tags:

JNJ, Janssen, ponesimod, Sanofi, Aubagio, relapsing multiple sclerosis

J&J scores Spravato trial win in high-risk depression. Will doctors and payers buy in?

Fierce Pharma

Tue, 09/10/19 - 11:31 am

Tags:

JNJ, clinical depression, high-risk depression, Spravato, physicians, payers

Who will be the biggest pharma players in orphan drugs?

Pharmaforum

Sat, 09/7/19 - 06:25 pm

Tags:

orphan drugs, Roche, M&A, AbbVie, JNJ

J&J gets Stelara okay in Europe for ulcerative colitis

Pharmaforum

Fri, 09/6/19 - 08:35 pm

Tags:

JNJ, Stelara, Janssen, Europe

How Will Johnson & Johnson's Opioid Case Ruling Impact Big Pharma Stocks?

Motley Fool

Thu, 09/5/19 - 08:17 pm

Tags:

opioids, opioid crisis, JNJ, McKesson, Mallinckrodt, Teva Pharmaceutical, Purdue Pharma, Par Pharma, Actavis

Beset by lawsuits and criticism in U.S., opioid makers eye new market in India

Fierce Pharma

Fri, 08/30/19 - 10:11 am

Tags:

India, opioids, JNJ, Mundipharma, Abbott Labs

Trump Wants the VA to Get as Much of This Drug as It Can

Motley Fool

Wed, 08/28/19 - 10:44 pm

Tags:

veterans, JNJ, Spravato, Donald Trump

Mark Your Calendar For These September PDUFA Dates

Yahoo/Benzinga

Wed, 08/28/19 - 12:53 pm

Tags:

FDA, Roche, Celgene, Tecentriq, Xeris Pharmaceuticals, Gvoke, Ardelyx, tenapanor, Merck, Pifeltro, Delstrigo, Novo Nordisk, semaglutide, JNJ, Genmab, daratumumab, Invokana

J&J Opioid Ruling 2019: 13 Things to Know

Yahoo/Investor Place

Tue, 08/27/19 - 10:49 pm

Tags:

JNJ, opioids, opioid crisis, Oklahoma

J&J found liable in Oklahoma opioid case and ordered to pay $572M; pledges to appeal

Fierce Pharma

Mon, 08/26/19 - 06:04 pm

Tags:

JNJ, opioids, opioid crisis, Oklahoma

FTC Issues Civil Investigative Demand to Johnson & Johnson Regarding Remicade

Big Molecule Watch

Sun, 08/25/19 - 05:02 pm

Tags:

Remicade, JNJ, Pfizer, antitrust, Walgreens, Kroger

Pages

last 30 twitter posts